🔎 Trials Near Me

Akèy › Maladi fwa steatotik › Michigan

Etid klinik pou Maladi fwa steatotik nan Michigan

8 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan Michigan.

Vil nan Michigan

Tèks ofisyèl etid la (Anglè)

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

  • University of Michigan, Ann Arbor
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT05832229

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  • Clinical Research Institute of Michigan, LLC, Clinton Township
  • Great Lakes Research Institute, Southfield
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  • Akero Clinical Study Site, Novi
  • Akero Clinical Study Site, Southfield
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06528314

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Chesterfield
  • 89bio Clinical Study Site, Wyoming
  • 89bio Clinical Study Site, Ypsilanti
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Ann Arbor
  • 89bio Clinical Study Site, Clinton Township
  • 89bio Clinical Study Site, Detroit
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 3, 2026 · NCT06419374

Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease

  • Henry Ford Health System, Detroit
Ap rekrite
Laj 30 a 70 · Tout sèks · Mizajou Aug 6, 2026 · NCT07646197

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

  • GSK Investigational Site, Detroit
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Aug 3, 2026 · NCT06613698

Thermoacoustic Method for Estimating Liver Fat Fraction

  • ENDRA Life Sciences, Ann Arbor
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT07321925

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.